...

首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Sampling Frame Stratification is Crucial in Evaluating the Effectiveness of Additional Risk Minimisation Activities (ARMAs)

【24h】

Sampling Frame Stratification is Crucial in Evaluating the Effectiveness of Additional Risk Minimisation Activities (ARMAs)

机译：抽样框架分层对于评估其他风险最小化活动（ARMA）的有效性至关重要

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Drug safety: An international journal of medical toxicology and drug experience》 |2014年第10期|共2页
作者
Banerjee A. K.; Ingate S.; Mayall S. J.; Boyall P.; Wells S.; Wooder S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药品;
关键词

相似文献

外文文献
中文文献
专利

1. Sampling Frame Stratification is Crucial in Evaluating the Effectiveness of Additional Risk Minimisation Activities (ARMAs) [J] . Banerjee A. K., Ingate S., Mayall S. J., Drug safety: An international journal of medical toxicology and drug experience . 2014,第10期

机译：抽样框架分层对于评估其他风险最小化活动（ARMA）的有效性至关重要
2. Pre/post effectiveness evaluation of updated additional risk minimisation measures for an orphan disease: Myozyme (alglucosidase alfa) Safety Information Packet [J] . Pharmacoepidemiology and drug safety . 2020,第1期

机译：预/后疗效评估孤儿疾病的更新额外风险最小化措施：咪唑酶（alglucosidase Alfa）安全信息包
3. An Innovative Software Tool for the Development, Implementation and Effectiveness Evaluation of Additional Risk Minimisation Measures [J] . Cushion M., Mayall S., Scrivener J., Drug safety: An international journal of medical toxicology and drug experience . 2015,第10期

机译：用于开发，实施和评估附加最小化风险措施的创新软件工具
4. EVALUATION OF THE RISK REDUCTION EFFECTIVENESS IN OSHA'S WORKPLACE SAMPLING ACTIVITIES [C] . Jeremy M. Gernand ASME international mechanical engineering congress and exposition . 2017

机译：OSHA的工作场所抽样活动中降低风险的效果评估
5. Segregation analyses in Ashkenazi Jewish families: Evidence of an additional breast cancer susceptibility gene, and evaluation of cancer risks in BRCA1/2 mutation carriers. [D] . Kaufman, David J. 2002

机译：阿什肯纳兹犹太人家庭的隔离分析：另一个乳腺癌易感基因的证据，以及BRCA1 / 2突变携带者的癌症风险评估。
6. Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder [O] . Elaine Agyemang, Lorna Bailey, John Talbot -1

机译：欧盟对药品采取的其他风险最小化措施：一位营销授权持有人对联合王国措施的实施和有效性进行回顾
7. Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe [O] . Steve Mayall, Randip Kahlon, Imad Al-Dakkak, 2021

机译：评估欧洲调查额外风险最小化措施的额外风险最小化措施的有效性
8. Governments Division Report Series: Stratification of a Sampling Frame with Auxiliary Data into Piecewise Linear Segments by Means of a Genetic Algorithm [R] . Barth, J. J., Cheng, Y. 2010

机译：政府部门报告系列：利用遗传算法将带有辅助数据的采样框架分层到分段线性分段中

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号